Table of Contents Author Guidelines Submit a Manuscript
Anemia
Volume 2015 (2015), Article ID 793025, 7 pages
http://dx.doi.org/10.1155/2015/793025
Research Article

Prevalence and Risk Factors for Complications in Patients with Nontransfusion Dependent Alpha- and Beta-Thalassemia

1Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, 110 Intravaroros Road, A. Muang, Chiang Mai 50200, Thailand
2Division of Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chiang Mai University, 110 Intravaroros Road, A. Muang, Chiang Mai 50200, Thailand

Received 31 May 2015; Accepted 5 November 2015

Academic Editor: Aurelio Maggio

Copyright © 2015 Poramed Winichakoon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. J. Giardina, “Thalassemia syndromes,” in Hematology: Basic Principles and Practice, R. Hoffman, E. J. Benz, and S. S. Shattil, Eds., Elsevier Churchill Livingstone, Philadelphia, Pa, USA, 5th edition, 2008. View at Google Scholar
  2. C. Camaschella and M. D. Cappellini, “Thalassemia intermedia,” Haematologica, vol. 80, no. 1, pp. 58–68, 1995. View at Google Scholar · View at Scopus
  3. M. D. Cappellini, K. M. Musallam, and A. T. Taher, “Insight onto the pathophysiology and clinical complications of thalassemia intermedia,” Hemoglobin, vol. 33, supplement 1, pp. S145–S159, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. F. El Rassi, M. D. Cappellini, A. Inati, and A. Taher, “Beta-thalassemia intermedia: an overview,” Pediatric Annals, vol. 37, no. 5, pp. 322–328, 2008. View at Google Scholar · View at Scopus
  5. K. M. Musallam, A. T. Taher, and E. A. Rachmilewitz, “β-thalassemia intermedia: a clinical perspective,” Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 7, Article ID a013482, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Taher, H. Isma'eel, and M. D. Cappellini, “Thalassemia intermedia: revisited,” Blood Cells, Molecules, and Diseases, vol. 37, no. 1, pp. 12–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. T. Taher, K. M. Musallam, and M. D. Cappellini, “Thalassaemia intermedia: an update,” Mediterranean Journal of Hematology and Infectious Diseases, vol. 1, no. 1, Article ID e2009004, 2009. View at Publisher · View at Google Scholar
  8. A. T. Taher, K. M. Musallam, M. Karimi et al., “Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study,” Blood, vol. 115, no. 10, pp. 1886–1892, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. J. E. Maakaron, M. D. Cappellini, and A. T. Taher, “An update on thalassemia intermedia,” Journal Medical Libanais, vol. 61, no. 3, pp. 175–182, 2013. View at Google Scholar · View at Scopus
  10. D. J. Weatherall, “The definition and epidemiology of non-transfusion-dependent thalassemia,” Blood Reviews, vol. 26, supplement 1, pp. S3–S6, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Borgna-Pignatti, M. Marsella, and N. Zanforlin, “The natural history of thalassemia intermedia,” Annals of the New York Academy of Sciences, vol. 1202, pp. 214–220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Isma'eel, A. H. E. Chafic, F. E. Rassi et al., “Relation between iron-overload indices, cardiac echo-Doppler, and biochemical markers in thalassemia intermedia,” American Journal of Cardiology, vol. 102, no. 3, pp. 363–367, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Karimi, K. M. Musallam, M. D. Cappellini et al., “Risk factors for pulmonary hypertension in patients with β thalassemia intermedia,” European Journal of Internal Medicine, vol. 22, no. 6, pp. 607–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. B. N. Matta, K. M. Musallam, J. E. Maakaron, S. Koussa, and A. T. Taher, “A killer revealed: 10-year experience with beta-thalassemia intermedia,” Hematology, vol. 19, no. 4, pp. 196–198, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. K. M. Musallam, M. D. Cappellini, and A. T. Taher, “Iron overload in β-thalassemia intermedia: an emerging concern,” Current Opinion in Hematology, vol. 20, no. 3, pp. 187–192, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Taher, F. El Rassi, H. Ismaeel, and A. Inati, “Complications of β-thalassemia intermedia: a 12-year Lebanese experience,” American Journal of Hematology, vol. 83, no. 7, pp. 605–606, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Taher, C. Hershko, and M. D. Cappellini, “Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies,” British Journal of Haematology, vol. 147, no. 5, pp. 634–640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. A. T. Taher, K. M. Musallam, and A. Inati, “The hypercoagulable state in thalassemia intermedia,” Hemoglobin, vol. 33, supplement 1, pp. S160–S169, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. J. E. Maakaron, “Complications and management of thalassemia intermedia,” Journal of Applied Hematology, vol. 3, no. 4, pp. 143–146, 2012. View at Google Scholar
  20. M. D. Cappellini, K. M. Musallam, E. Poggiali, and A. T. Taher, “Hypercoagulability in non-transfusion-dependent thalassemia,” Blood Reviews, vol. 26, no. 1, pp. S20–S23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Camaschella, U. Mazza, A. Roetto et al., “Genetic interactions in thalassemia intermedia: Analysis of β-mutations, α-genotype, γ-promoters, and β-LCR hypersensitive sites 2 and 4 in Italian patients,” American Journal of Hematology, vol. 48, no. 2, pp. 82–87, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. C. Camaschella, G. Saglio, A. Serra et al., “Molecular characterization of thalassemia intermedia in Italy,” Birth Defects Original Article Series, vol. 23, no. 5, pp. 111–116, 1987. View at Google Scholar · View at Scopus
  23. F. X. Kleber, L. Niemoller, and W. Doering, “Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial,” British Heart Journal, vol. 67, no. 4, pp. 289–296, 1992. View at Publisher · View at Google Scholar · View at Scopus
  24. K. M. Musallam, M. D. Cappellini, J. C. Wood, and A. T. Taher, “Iron overload in non-transfusion-dependent thalassemia: a clinical perspective,” Blood Reviews, vol. 26, no. 1, pp. S16–S19, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Nuntakarn, S. Fucharoen, G. Fucharoen, K. Sanchaisuriya, A. Jetsrisuparb, and S. Wiangnon, “Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-β-thalassemia in Northeast Thailand,” Blood Cells, Molecules, and Diseases, vol. 42, no. 1, pp. 32–35, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. I. C. Verma, M. Kleanthous, R. Saxena et al., “Multicenter study of the molecular basis of thalassemia intermedia in different ethnic populations,” Hemoglobin, vol. 31, no. 4, pp. 439–452, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. K. M. Musallam, A. Beydoun, R. Hourani et al., “Brain magnetic resonance angiography in splenectomized adults with β-thalassemia intermedia,” European Journal of Haematology, vol. 87, no. 6, pp. 539–546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Fucharoen, H. Srivorakun, S. Singsanan, and S. Fucharoen, “Presumptive diagnosis of common haemoglobinopathies in Southeast Asia using a capillary electrophoresis system,” International Journal of Laboratory Hematology, vol. 33, no. 4, pp. 424–433, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Fucharoen, Thalassemia: From Molecular Biology to Clinical Medicine, Mahidol University, Bangkok, Thailand, 2007.
  30. S. Fucharoen and P. Winichagoon, “Haemoglobinopathies in Southeast Asia,” Indian Journal of Medical Research, vol. 134, no. 10, pp. 498–506, 2011. View at Google Scholar · View at Scopus
  31. P. Angchaisuksiri, V. Atichartakarn, K. Aryurachai et al., “Risk factors of venous thromboembolism in Thai patients,” International Journal of Hematology, vol. 86, no. 5, pp. 397–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. A. T. Taher, K. M. Musallam, M. Karimi et al., “Splenectomy and thrombosis: the case of thalassemia intermedia,” Journal of Thrombosis and Haemostasis, vol. 8, no. 10, pp. 2152–2158, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. E. B. Fung, P. R. Harmatz, P. D. K. Lee et al., “Increased prevalence of iron-overload associated endocrinopathy in thalassaemia versus sickle-cell disease,” British Journal of Haematology, vol. 135, no. 4, pp. 574–582, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. K. M. Musallam, M. D. Cappellini, and A. T. Taher, “Evaluation of the 5mg/g liver iron concentration threshold and its association with morbidity in patients with β-thalassemia intermedia,” Blood Cells, Molecules, and Diseases, vol. 51, no. 1, pp. 35–38, 2013. View at Publisher · View at Google Scholar · View at Scopus